vaccine contract manufacturing market 2025 to 2034
vaccine contract manufacturing market 2025 to 2034
Vaccine Contract Manufacturing Market (By Vaccine Type: Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based; By Workflow: Downstream, Upstream; By Application: Human Use, Veterinary; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 4.72 Bn
Forecast Year, 2034
USD 12.26 Bn
CAGR, 2025 - 2034
11.20%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global vaccine contract manufacturing market, valued at USD 4.72B in 2025, is projected to reach USD 12.26B by 2034, growing at a CAGR of 11.2%, driven by rising demand for outsourced vaccine production and advanced biopharmaceutical collaborations.
vaccine contract manufacturing market Size Analysis
vaccine contract manufacturing market Size By Vaccine Type 2025 to 2034 (USD Billion)
| Vaccine Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Attenuated | 0.32 | 0.35 | 0.39 | 0.44 | 0.49 | 0.54 | 0.60 | 0.66 | 0.74 | 0.82 |
| Inactivated | 0.63 | 0.70 | 0.78 | 0.87 | 0.97 | 1.07 | 1.19 | 1.33 | 1.48 | 1.64 |
| Subunit-based | 0.95 | 1.05 | 1.17 | 1.30 | 1.44 | 1.61 | 1.78 | 1.99 | 2.21 | 2.46 |
| Toxoid-based | 1.26 | 1.40 | 1.56 | 1.73 | 1.92 | 2.13 | 2.38 | 2.64 | 2.94 | 3.27 |
| DNA-based | 1.57 | 1.75 | 1.94 | 2.16 | 2.40 | 2.67 | 2.97 | 3.30 | 3.67 | 4.08 |
vaccine contract manufacturing market Size By Workflow 2025 to 2034 (USD Billion)
| Workflow | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Downstream | 1.58 | 1.75 | 1.95 | 2.18 | 2.41 | 2.70 | 2.97 | 3.32 | 3.67 | 4.07 |
| Upstream | 3.14 | 3.50 | 3.89 | 4.31 | 4.81 | 5.32 | 5.95 | 6.61 | 7.36 | 8.20 |
vaccine contract manufacturing market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Human Use | 1.59 | 1.75 | 1.96 | 2.17 | 2.41 | 2.68 | 3.01 | 3.31 | 3.67 | 4.08 |
| Veterinary | 3.13 | 3.50 | 3.88 | 4.33 | 4.81 | 5.35 | 5.92 | 6.61 | 7.36 | 8.19 |
vaccine contract manufacturing market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.48 | 0.53 | 0.58 | 0.66 | 0.73 | 0.81 | 0.90 | 1.01 | 1.12 | 1.23 |
| LAMEA | 0.94 | 1.05 | 1.17 | 1.30 | 1.44 | 1.61 | 1.78 | 1.98 | 2.20 | 2.46 |
| Europe | 1.42 | 1.57 | 1.75 | 1.94 | 2.16 | 2.40 | 2.68 | 2.98 | 3.31 | 3.68 |
| Asia-Pacific | 1.89 | 2.10 | 2.33 | 2.59 | 2.88 | 3.20 | 3.56 | 3.96 | 4.40 | 4.90 |
vaccine contract manufacturing market Size to Hit USD 12.26 Billion by 2034
The global vaccine contract manufacturing market size accounted for USD 4.72 billion in 2025 and is predicted to touch around USD 12.26 billion by 2034 with a growing at a CAGR of 11.20%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
